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Summary One hundred patients operated for large bowel carcinoma were divided into a distinct aneuploid
group of 63, and a near diploid one of 37. Flow cytometry was used for determination of the DNA ploidy
pattern. All tumours in the aneuploid group contained one or more aneuploid cell populations. All patients
were followed clinically from 3.5 to 7.8 years. The corrected 5 year survival was 64% and 49% for patients
with near diploid and aneuploid tumours, respectively (not significant). Significant differences in corrected
survival time were not observed for Dukes' stages A, B, and C patients pooled, nor for Dukes' stage D
patients. However, for Dukes' stage C patients alone, there was a tendency (P=0.10) for patients with near
diploid tumours to show a better survival. A highly significant predominance of aneuploid tumours was seen
in males, in contrast to an equal distribution of aneuploid and near diploid tumours in females. A slight
predominance of aneuploid tumours in the left colon and rectum was seen. Both these findings indicate the
influence of environmental factors (hormonal, anatomical, phenotypical) on the development of tumours with
a particular DNA ploidy pattern.
Flow cytometric DNA determination have become
commonplace in studies of human solid tumours (Laerum &
Farsund, 1981; Friedlander et al., 1984). It is, however,
uncertain to what extent the DNA ploidy pattern is
associated with the clinical course of disease. It appears that
different criteria are valid for solid tumours arising in
different organs of the human body. Wolley et al. (1982)
reported a significantly better survival for patients operated
for 'diploid' adenocarcinomas of the colon than for those
operated for 'aneuploid' tumours. They followed 33 patients
for 3-5 years but concluded that their observations required
confirmation by additional data. So far Armitage et al.
(1985) and Kokal et al. (1986) have confirmed the findings
of Wolley et al. (1982) whereas Melamed et al. (1986) in a
study of 33 patients at all stages, and Finan et al. (1986) in
46 cases of advanced colorectal carcinomas found no
significant difference in survival.
The present communication is an attempt to test the
conclusion drawn by Wolley et al. (1982) on a larger series
ofpatients observed for a longer period of time.
Materials and methods
Samples
From 1978 to 1982 tumour specimens from 100 consecutive
patients operated for large bowel carcinoma were studied by
flow cytometry. In the majority, the cases 5 samples from
each tumour were analysed.
DNAflow cytometry
Single cell suspensions were prepared immediately after
tumour excision by mincing the tissue in PBS, pH 7.6,
followed by filtration through a nylon mesh (pore size
70pm). The cells were fixed in ice-cold absolute ethanol and
kept in 70% ethanol, until processed for flow cytometry by
exposure to RNAse and pepsin prior to the staining
procedure of Godhe and Dittrich (1971) with ethidium
bromide. Emission measurements were performed in an ICP
11 flow cytometer (Phywe AG, G6ttingen, FRG). DNA
histograms were analysed by planimetry. Mouse spleen
lymphocytes were used as a diploid (2c) reference, and peaks
above 2.5c relative to the lymphocyte level were regarded as
distinctly aneuploid. When no such peak was identified the
tumour was assigned near diploid. Minor 4c peaks may
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represent G2 cells of the diploid GI population, GI cells of
a tetraploid cell population, or both in combination. When
the area under the 4c peak was larger than that between the
2c and 4c level, the 4c peak was considered to represent an
aneuploid cell population. This seems justified, since in
proliferating mammalian cell populations the proportion of
cells in G2 phase is generally lower than that in the S phase
(for review see Steel, 1977). However, additional
interpretative problems were occasionally caused by
clumping of 2c cells. This phenomenon could be identified at
the 6c level, 8c level and eventually at the 1Oc level or
higher. When the area of the 6c peak exceeded 10% of the
4c peak, with no further peaks at higher ploidy levels, the 4c
peak was considered to represent clumping, and the tumour
was assigned as near diploid.
Clinicopathological evaluation andfollow-up ofthe patients
Sex and age of the patients were recorded and clinicopatho-
logical staging was done according to an extended Dukes'
scheme (Turnbull et al., 1967), which in addition to Dukes'
stages A, B and C, ascribe stage D to tumours with distant
organ metastases and inoperable primary tumour. Gross
pathological examination and staging was performed by the
same observer (TOR) throughout the study. Furthermore,
the histological grade (Ashley, 1978), and the localization
of the tumours were recorded. The follow-up period varied
between 3.5 years and 7.8 years (median 5.8 years). Survival
rates were computed by the actuarial or life table method.
Crude survival was based on all deaths, while for corrected
survival rates deaths not due to cancer were censored.
Information about recurrences and deaths due to cancer was
obtained from the hospital records or the post mortem
reports. For the whole patient material, information with
regard to time of death has been controlled against the files
of the Norwegian Cancer Registry. This Registry obtains the
information from the Central Bureau of Statistics. The log-
rank procedure was used to assess the statistical significance
between survival distribution (Mantel, 1966).
Results
Sixty-three patients had tumours with distinctly aneuploid
DNA ploidy patterns, whereas 37 were near diploid (Figure
1; Table I). In most cases the CV of the histograms was
-5% (range 2-14%). Clinicopathological data on the 100
patients is given in Table I. There were significantly more
near diploid tumours in the female patients than in the males
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different DNA ploidy
patients with patients with
near diploid aneuploid
tumours tumours P
Crude survival 53 44 0.32
Corrected survival 64 49 0.19
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(P<0.01). Near diploid tumours also tended to be more
frequent in the right than the left part of the large bowel
(P=0.12).
The crude survival rate for the two ploidy groups did not
differ significantly (P=0.32) (Table II). However, when
corrected for cancer specific deaths, there was a weak trend
towards a somewhat poorer survival for patients with
aneuploid compared with near diploid tumours (Figure 2).
The 5 year corrected survival rates for patients with near
diploid and aneuploid tumours were 64% and 49%
respectively for the whole group (Table II) (P=0.19). In
Figure 3, the corrected survival times are given for each of
the Dukes' stages according to DNA ploidy. For patients
with locally advanced tumours (Duke's stage C) a trend is
indicated (P=0.10) with better survival in the near diploid
group. The 5 year survival rates for this group of patients
were 60% and 20% for patients with near diploid and
aneuploid tumours respectively (Figure 3). However, for
pooled Dukes' A, B and C patients and for Dukes' D
patients alone, no significant difference in survival could be
established.
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Figure 1 DNA histograms, (a) of a near diploid large bowel
carcinoma, and (b) of a large bowel carcinoma with a distinct
aneuploid cell population in addition to the near diploid one.
Diploid (2c) levels (mouse lymphocyte fluorescence) are indicated
by arrows (LY).
Table I Clinicopathological characteristics of the patients according
to DNA ploidy
Near diploid Aneuploid Total
No. No. No.
No. ofpatients 37 63 100
Sex Male 12 40 48
Female 25 23 52
Mean age years 63.0 66.5 64.5
(range yr) (41-82) (28-89) (28-89)
Mean follow up (yr) 5.75 5.6 5.8
(range yr) (3.7-7.8) (3.5-8.7) (3.5-7.75)
Dukes' stage A 8 13 21
B 15 23 38
C 10 15 25
D 4 12 16
Histological grade
Well differentiated 5 6 11
Moderately differentiated 27 42 69
Poorly differentiated 5 15 20
Localization
Right colon 17 15 32
Left colon/rectum 20 48 68
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Figure 2 Survival curves (corrected for death not due to cancer)
for patients with near diploid 0 O and aneuploid 0 ----0
tumours (P=0.19).
Discussion
For large bowel carcinoma patients an aneuploid tumour has
been claimed to be a poor prognostic sign (Atkin & Kay,
1979; Wolley et al., 1982; Armitage et al., 1985; Kokal et al.,
1986). Others, however (Melamed et al., 1986; Finan et al.,
1986), were unable to demonstrate differences in survival
between patients with aneuploid tumours and those with
near diploid ones. The present study does not give
unambiguous support to the finding of Wolley et al. (1982),
Armitage et al. (1985) and Kokal et al. (1986), and indicates
only that patients with aneuploid tumours of the large bowel
tend to have a poorer prognosis than those with near diploid
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Figure 3 Survival rates (corrected for death not due to cancer) for patients with near diploid 0 O and aneuploid 0--
tumours of Dukes' stage A, B, and C.
neoplasms (Table II; Figures 2 & 3). The trend is, however,
much weaker than in the previous reports (Wolley et al.,
1982; Kokal et al., 1986) and does not reach statistical
significance. A critical point is the definition of aneuploidy.
However, despite a vaguely defined system by Wolley et al.
(1982), the criteria used for dividing the tumours into near
diploid and aneuploid seem roughly equivalent to those
applied in the present paper. The group of aneuploid
tumours may thus be regarded as 'homogeneous' in this
respect while the near diploid group consists of true diploid
tumours, near diploid tumours and aneuploid tumours, the
proportion of aneuploid cells being too low for detection in
the system and by the criteria used. Thus the near diploid
group is 'heterogeneous', and complicates the interpretation.
Despite the use of equivalent criteria by Wolley et al. (1982)
to those of the present study, relatively more near diploid
tumours were found in the former series. This is based on
the assumption that the techniques and staining methods
used generate approximately the same fluorescence
characteristics, proportional to nuclear DNA. The problem
of intratumour variation of the DNA profile is discussed in
detail elsewhere (Rognum et al., 1981; Petersen et al., 1981).
Different distribution of ploidy patterns in the tumours
might thus be one reason for the apparent discrepancy
between the findings of Wolley et al. (1982) and the present
report. Most authors find that between 50 and 70% of large
bowel carcinomas are aneuploid (Rognum et al., 1981;
Petersen et al., 1981; Rognum et al., 1982; Tribukait et al.,
1983; Frankfurt et al., 1984; Valet et al., 1984; Quirke et al.,
1985,1987; Kokal et al., 1986). In the series of Wolley et al.
(1982), Dukes' stage C aneuploid tumours were predominant
and conventional prognostic factors contributed proportion-
ately little to the clinical outcome. Only Perrez et al. (1981)
find a majority of diploid tumours. However, their series of
patients was very small, and lacked clinical data. In Dukes'
C patients surgery is frequently not 'curative' and the natural
history of these patients might elucidate the behaviour of
tumours with different ploidy pattern (Figure 3) better than
patients with Dukes' stage tumours A and B. It is thus
interesting that patients with Dukes' C tumours showed the
most distinct tendency towards different survival between the
aneuploid and the near diploid groups. However, for neither
pooled Dukes' A, B and C tumours, nor Dukes' D tumours
alone, could any significant difference in survival between
the ploidy groups be found. This contrasts with the finding
of Quirke et al. (1987) who found that ploidy was
significantly related to survival in stage A, B and C patients
with rectal adenocarcinomas.
Twenty-one percent of the patients in the present study
had Dukes' stage A tumours. This relatively high percentage
might be due to the fact that most patients were admitted to
a secondary centre, not being emergency cases.
Male patients had significantly more frequent aneuploid
tumours than females (Table I). We have no reasonable
explanation for this finding, except that hormones may
possibly influence tumour development. Near diploid breast
carcinomas were more frequent in premenopausal women
(Thorud et al., 1986). Male sex hormones could conceivably
influence host defence and clonal selection, favoring the
development of aneuploid carcinomas.
Another observation, for which we have no clear
explanation, is the tendency for aneuploid tumours to be
more frequent in the left colon and rectum than in the right
colon (Table I). Environmental factors in the left colon
might stimulate the development of aneuploid cell clones.
A number of reports, dealing with solid tumours arising
in various organs, have demonstrated the prognostic
significance of DNA ploidy pattern. Atkin (1976), using
Feulgen microspectrophotometry, found a worse prognosis
for patients with near diploid squamous cell carcinoma of
the uterine cervix than for those with tumours of high
ploidy. The inverse relationship was found for patients with
endometrial carcinomas. In a broader presentation, Atkin
and Kay (1979) found that for all sites except the cervix
uteri, patients with near diploid tumours had the better
survival. More recently a number of studies have
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demonstrated that aneuploid solid tumours carry a worse
prognosis. This is observed with microspectrophotometry or
flow cytometry techniques for non-small cell lung carcinomas
(Volm et al., 1985a), small cell lung carcinoma (Abe et al.,
1985), and ovarian carcinomas (Volm et al., 1985b).
Although the prognostic significance of the DNA ploidy
pattern is less clearcut than reported by Wolley et al. (1982)
and Kokal et al. (1986), DNA quantitation used in
combination with other variables such as class II HLA-DR
determinants (Rognum et al., 1983), might add important
biological information. It has furthermore been shown that
carcinomas with an aneuploid DNA ploidy profile have a
greater output of CEA than those with a near diploid DNA
ploidy profile (Rognum et al., 1982, 1986, 1987). Thus
information on tumour DNA ploidy and serial CEA
measurements might facilitate early detection of recurrence
(Rognum, 1986).
Clinicopathological staging remains the most significant
variable in the assessment of prognosis in patients with large
bowel carcinoma. Flow cytometric determination of tumour
DNA ploidy might, however, add valuable clinical
information in Dukes' stage C patients.
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